These findings reveal a worrying trend: the pandemic significantly delayed recurrence diagnosis and was associated with an increased risk of death after recurrence.
← all excerpts
Delayed diagnosis and increased mortality risk: Assessing the effects of the COVID-19 pandemic on breast cancer recurrence
1
—
—